Infectious Disease

Category

New NIH Investigator Network: NIAID Commits $82m to Form Center for Research in Emerging Diseases (CREID)

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced that it has awarded 11 grants with a total first-year value of approximately $17 million to establish the Centers for Research in Emerging...

The Race to Find a COVID-19 Vaccine: The INO-4800 Study Participation at the University of Pennsylvania

Worldwide, over 125 COVID-19 vaccines are now in development, while only a handful have progressed to human clinical trials. Of those vaccines currently undergoing clinical trials, Inovio Pharmaceuticals started recruiting patients in April 2020 to test the INO-4800...

SCYNEXIS Reports Data from Second Interim Analysis of Ongoing Phase 3 FURI Study, Oral Ibrexafungerp Effective in Treating Severe Fungal Infections in Hospital Setting

SCYNEXIS announced positive results from its second interim efficacy analysis of the ongoing Phase 3 open-label FURI study. The study is evaluating oral ibrexafungerp as a salvage treatment in patients with difficult-to-treat mucocutaneous and invasive fungal...

Pin It on Pinterest